Century Therapeutics, Inc. (IPSC)

Century Therapeutics Statistics

Total Valuation

IPSC has a market cap or net worth of $103.31 million. The enterprise value is -$36.38 million.

Market Cap	103.31M
Enterprise Value	-36.38M

Important Dates

The last earnings date was Tuesday, November 5, 2024, before market open.

Earnings Date	Nov 5, 2024
Ex-Dividend Date	n/a

Share Statistics

IPSC has 85.03 million shares outstanding. The number of shares has increased by 22.76% in one year.

Current Share Class	85.03M
Shares Outstanding	85.03M
Shares Change (YoY)	+22.76%
Shares Change (QoQ)	+3.18%
Owned by Insiders (%)	4.36%
Owned by Institutions (%)	38.19%
Float	38.72M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	33.94
Forward PS	8.58
PB Ratio	0.55
P/TBV Ratio	0.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.39, with a Debt / Equity ratio of 0.28.

Current Ratio	10.39
Quick Ratio	10.06
Debt / Equity	0.28
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -62.61% and return on invested capital (ROIC) is -31.78%.

Return on Equity (ROE)	-62.61%
Return on Assets (ROA)	-20.90%
Return on Capital (ROIC)	-31.78%
Revenue Per Employee	$16,267
Profits Per Employee	-$787,218
Employee Count	165
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-855,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.04% in the last 52 weeks. The beta is 1.42, so IPSC's price volatility has been higher than the market average.

Beta (5Y)	1.42
52-Week Price Change	-15.04%
50-Day Moving Average	1.46
200-Day Moving Average	2.67
Relative Strength Index (RSI)	38.54
Average Volume (20 Days)	485,825

Short Selling Information

The latest short interest is 3.52 million, so 4.15% of the outstanding shares have been sold short.

Short Interest	3.52M
Short Previous Month	3.33M
Short % of Shares Out	4.15%
Short % of Float	9.10%
Short Ratio (days to cover)	10.09

Income Statement

In the last 12 months, IPSC had revenue of $2.68 million and -$129.89 million in losses. Loss per share was -$1.80.

Revenue	2.68M
Gross Profit	-97.48M
Operating Income	-131.47M
Pretax Income	-131.64M
Net Income	-129.89M
EBITDA	-117.93M
EBIT	-131.47M
Loss Per Share	-$1.80

Balance Sheet

The company has $198.11 million in cash and $54.60 million in debt, giving a net cash position of $143.52 million or $1.69 per share.

Cash & Cash Equivalents	198.11M
Total Debt	54.60M
Net Cash	143.52M
Net Cash Per Share	$1.69
Equity (Book Value)	195.69M
Book Value Per Share	2.31
Working Capital	186.19M

Cash Flow

In the last 12 months, operating cash flow was -$112.14 million and capital expenditures -$980,000, giving a free cash flow of -$113.12 million.

Operating Cash Flow	-112.14M
Capital Expenditures	-980,000
Free Cash Flow	-113.12M
FCF Per Share	-$1.33

Margins

Gross Margin	n/a
Operating Margin	-4,898.29%
Pretax Margin	-4,871.31%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-5,019.98%

Dividends & Yields

IPSC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.76%
Shareholder Yield	-22.76%
Earnings Yield	-121.24%
FCF Yield	-105.59%

Analyst Forecast

The average price target for IPSC is $13.00, which is 969.96% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.00
Price Target Difference	969.96%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	121.04%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

IPSC has an Altman Z-Score of -2.62 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.62
Piotroski F-Score	4